Balance Sheet Align Technology, Inc.

Equities

ALGN

US0162551016

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 01:30:00 18/09/2024 am IST			5-day change	1st Jan Change
253.16 ^USD	+1.44%		+11.45%	-7.61%

10/09	Transcript : Align Technology, Inc. Presents at Baird's 2024 Global Healthcare Conference, Sep-10-2024 09:05 AM
04/09	Align Technology Announces New Regional Leadership Roles	CI

d2340c41ea1603.DSKgJJ4UgqWJyOYiOIWkWSt7fkqgTvAjBEnLqr0b9Nk.QX2VVvB_2P3vpLIQWtX1MnQpGQLlPZRTQ3qy8_tJp-hmfehc3E7Oz7z5qw

Published financial data: ALIGN TECHNOLOGY, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	240.68Cr	247.19Cr	395.26Cr	373.46Cr	386.23Cr
Total Revenues	240.68Cr	247.19Cr	395.26Cr	373.46Cr	386.23Cr
Cost of Goods Sold, Total	66Cr	71Cr	101.72Cr	109.8Cr	114.21Cr
Gross Profit	174.39Cr	176.32Cr	293.54Cr	263.67Cr	272.02Cr
Selling General & Admin Expenses, Total	107.21Cr	120.08Cr	170.86Cr	167.45Cr	170.34Cr
R&D Expenses	16Cr	18Cr	25Cr	31Cr	35Cr
Other Operating Expenses	-	-	-	53T	1.33Cr
Other Operating Expenses, Total	122.94Cr	137.61Cr	195.9Cr	197.98Cr	206.35Cr
Operating Income	51Cr	39Cr	98Cr	66Cr	66Cr
Interest And Investment Income	1.25Cr	31.25L	31.03L	53.67L	1.73Cr
Net Interest Expenses	1.25Cr	31.25L	31.03L	53.67L	1.73Cr
Income (Loss) On Equity Invest.	-75.28L	-	-	-	-
Currency Exchange Gains (Loss)	-20L	68L	-1.33Cr	-4.38Cr	-70L
Other Non Operating Income (Expenses)	-20.93L	-20.6L	28.17L	-51.05L	-1.24Cr
EBT, Excl. Unusual Items	52Cr	40Cr	97Cr	61Cr	65Cr
Restructuring Charges	-	-	-	-1.02Cr	-1.33Cr
Merger & Related Restructuring Charges	-	-1.02Cr	-	-	-
Gain (Loss) On Sale Of Investments	1.18Cr	-58.87L	-	-	-
Asset Writedown	-	-	-	-18L	-
Legal Settlements	2.8Cr	-	4.34Cr	-	-
Other Unusual Items	-	-	-	-23L	-
EBT, Incl. Unusual Items	56Cr	38Cr	101.24Cr	60Cr	64Cr
Income Tax Expense	11Cr	-139.69Cr	24Cr	24Cr	20Cr
Earnings From Continuing Operations	44Cr	177.59Cr	77Cr	36Cr	45Cr
Net Income to Company	44Cr	177.59Cr	77Cr	36Cr	45Cr
Net Income - (IS)	44Cr	177.59Cr	77Cr	36Cr	45Cr
Net Income to Common Incl Extra Items	44Cr	177.59Cr	77Cr	36Cr	45Cr
Net Income to Common Excl. Extra Items	44Cr	177.59Cr	77Cr	36Cr	45Cr
Per Share Items
Net EPS - Basic	5.57	22.55	9.78	4.62	5.82
Basic EPS - Continuing Operations	5.57	22.55	9.78	4.62	5.82
Basic Weighted Average Shares Outstanding	7.94Cr	7.88Cr	7.89Cr	7.82Cr	7.64Cr
Net EPS - Diluted	5.53	22.41	9.69	4.61	5.81
Diluted EPS - Continuing Operations	5.53	22.41	9.69	4.61	5.81
Diluted Weighted Average Shares Outstanding	8.01Cr	7.92Cr	7.97Cr	7.84Cr	7.66Cr
Normalized Basic EPS	4.06	3.13	7.67	4.9	5.35
Normalized Diluted EPS	4.02	3.12	7.6	4.89	5.34
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	60Cr	48Cr	108.51Cr	78Cr	80Cr
EBITA	52Cr	40Cr	99Cr	67Cr	67Cr
EBIT	51Cr	39Cr	98Cr	66Cr	66Cr
EBITDAR	62Cr	51Cr	112.95Cr	84Cr	86Cr
Effective Tax Rate - (Ratio)	20.24	-368.64	23.75	39.64	30.59
Current Domestic Taxes	8.57Cr	6.42Cr	19Cr	22Cr	16Cr
Current Foreign Taxes	2.84Cr	2.94Cr	4.27Cr	5.65Cr	5.13Cr
Total Current Taxes	11Cr	9.36Cr	23Cr	28Cr	21Cr
Deferred Domestic Taxes	14.44L	-1.39Cr	-3.15Cr	-6.78Cr	-2Cr
Deferred Foreign Taxes	-31.58L	-147.66Cr	4.34Cr	2.61Cr	19.4L
Total Deferred Taxes	-17.14L	-149.05Cr	1.2Cr	-4.17Cr	-1.8Cr
Normalized Net Income	32Cr	25Cr	61Cr	38Cr	41Cr
Supplemental Operating Expense Items
Advertising Expense	12Cr	16Cr	33Cr	-	-
Selling and Marketing Expenses	12Cr	16Cr	33Cr	-	-
General and Administrative Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	16Cr	18Cr	25Cr	31Cr	35Cr
Net Rental Expense, Total	2.47Cr	2.93Cr	4.44Cr	6Cr	6.06Cr
Stock-Based Comp., COGS (Total)	51.54L	47.19L	56.33L	64.38L	74.62L
Stock-Based Comp., R&D Exp. (Total)	1.32Cr	1.52Cr	1.8Cr	2.38Cr	3.06Cr
Stock-Based Comp., S&M Exp. (Total)	-	-	-	-	-
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	6.98Cr	7.85Cr	9.07Cr	10Cr	12Cr
Total Stock-Based Compensation	8.82Cr	9.84Cr	11Cr	13Cr	15Cr

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	55Cr	96Cr	109.94Cr	94Cr	94Cr
Short Term Investments	32Cr	-	7.2Cr	5.75Cr	3.53Cr
Total Cash And Short Term Investments	87Cr	96Cr	117.13Cr	100Cr	97Cr
Accounts Receivable, Total	55Cr	66Cr	90Cr	86Cr	90Cr
Other Receivables	4.57Cr	4.52Cr	-	14Cr	14Cr
Notes Receivable	2.5Cr	54.08L	-	-	-
Total Receivables	62Cr	71Cr	90Cr	100.02Cr	104.72Cr
Inventory	11Cr	14Cr	23Cr	34Cr	30Cr
Prepaid Expenses	2.46Cr	1.4Cr	7.02Cr	6.91Cr	5.25Cr
Deferred Tax Assets Current	-	-	-	-	-
Restricted Cash	-	-	-	-	-
Other Current Assets, Total	71.28L	2.71Cr	13Cr	1.68Cr	7.73Cr
Total Current Assets	163.34Cr	184.95Cr	249.41Cr	242.44Cr	244.66Cr
Gross Property Plant And Equipment	92Cr	111.85Cr	156.23Cr	180.05Cr	195.96Cr
Accumulated Depreciation	-23Cr	-30Cr	-36Cr	-45Cr	-55Cr
Net Property Plant And Equipment	69Cr	82Cr	120.32Cr	135.07Cr	140.89Cr
Long-term Investments	58.87L	-	13Cr	4.2Cr	80.22L
Goodwill	6.39Cr	44Cr	42Cr	41Cr	42Cr
Other Intangibles, Total	1.18Cr	13Cr	11Cr	9.57Cr	8.21Cr
Loans Receivable Long-Term	73.28L	-	-	-	-
Deferred Tax Assets Long-Term	6.4Cr	155.28Cr	153.38Cr	157.17Cr	159Cr
Deferred Charges Long-Term	-	2.28Cr	3.11Cr	2.74Cr	2.51Cr
Other Long-Term Assets, Total	2.64Cr	1.24Cr	1.78Cr	2.84Cr	10Cr
Total Assets	250.07Cr	482.97Cr	594.21Cr	594.79Cr	608.39Cr
Liabilities
Accounts Payable, Total	8.72Cr	14Cr	16Cr	13Cr	11Cr
Accrued Expenses, Total	29Cr	31Cr	49Cr	32Cr	43Cr
Current Portion of Leases	1.57Cr	2.17Cr	2.27Cr	2.66Cr	2.97Cr
Current Income Taxes Payable	1.41Cr	3.01Cr	3.38Cr	7.43Cr	3.81Cr
Unearned Revenue Current, Total	56Cr	78Cr	115.29Cr	134.36Cr	142.77Cr
Other Current Liabilities	-	4.03Cr	6.27Cr	3.78Cr	2.36Cr
Total Current Liabilities	97Cr	132.56Cr	192.41Cr	192.59Cr	206.66Cr
Long-Term Leases	4.35Cr	6.44Cr	10Cr	10Cr	9.7Cr
Unearned Revenue Non Current	3.55Cr	6.26Cr	14Cr	16Cr	14Cr
Other Non Current Liabilities	10Cr	14Cr	16Cr	16Cr	15Cr
Total Liabilities	115.45Cr	159.58Cr	231.94Cr	234.66Cr	245.34Cr
Common Stock, Total	8T	8T	8T	8T	7T
Additional Paid In Capital	91Cr	97Cr	100Cr	104.49Cr	116.21Cr
Retained Earnings	44Cr	221.58Cr	261.94Cr	256.67Cr	244.72Cr
Comprehensive Income and Other	-7L	4.35Cr	43.26L	-1.03Cr	2.12Cr
Total Common Equity	134.62Cr	323.39Cr	362.27Cr	360.14Cr	363.05Cr
Total Equity	134.62Cr	323.39Cr	362.27Cr	360.14Cr	363.05Cr
Total Liabilities And Equity	250.07Cr	482.97Cr	594.21Cr	594.79Cr	608.39Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	7.88Cr	7.91Cr	7.88Cr	7.66Cr	7.51Cr
ECS Total Common Shares Outstanding	7.84Cr	7.89Cr	7.87Cr	7.73Cr	7.51Cr
Book Value / Share	17.16	41.01	46.03	46.61	48.36
Tangible Book Value	127.05Cr	265.9Cr	309.45Cr	309.81Cr	312.88Cr
Tangible Book Value Per Share	16.2	33.72	39.31	40.1	41.68
Total Debt	5.92Cr	8.62Cr	13Cr	13Cr	13Cr
Net Debt	-81Cr	-87Cr	-117.13Cr	-91Cr	-85Cr
Debt Equivalent Oper. Leases	20Cr	23Cr	36Cr	48Cr	49Cr
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	3	3	5	5	5
Inventories - Raw Materials, Total	5.49Cr	7.64Cr	12Cr	17Cr	15Cr
Inventories - Work In Process, Total	3.1Cr	3.14Cr	5.17Cr	9.66Cr	9.13Cr
Inventories - Finished Goods, Total	2.61Cr	3.14Cr	5.53Cr	6.94Cr	6.02Cr
Land - (BS)	2.64Cr	3.46Cr	5.89Cr	5.89Cr	6.39Cr
Buildings, Total	21Cr	24Cr	31Cr	47Cr	52Cr
Machinery, Total	39Cr	47Cr	52Cr	69Cr	83Cr
Full Time Employees	14.53T	18.07T	22.54T	23.16T	21.61T
Accumulated Allowance for Doubtful Accounts (Supple)	67.56L	1.02Cr	92.45L	1.03Cr	1.49Cr
Order Backlog	-	87Cr	-	-	-

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	44Cr	177.59Cr	77Cr	36Cr	45Cr
Depreciation & Amortization - CF	7.9Cr	8.01Cr	9.21Cr	11Cr	13Cr
Amortization of Goodwill and Intangible Assets - (CF)	59L	1.34Cr	1.66Cr	1.6Cr	1.64Cr
Depreciation & Amortization, Total	8.49Cr	9.35Cr	11Cr	13Cr	14Cr
(Gain) Loss on Sale of Investments - (CF)	-1.58Cr	58.87L	-	-	49.9L
Asset Writedown & Restructuring Costs	2.85Cr	-	-	-	-
(Income) Loss On Equity Investments - (CF)	75.28L	-	-	-	-
Stock-Based Compensation (CF)	8.82Cr	9.84Cr	11Cr	13Cr	15Cr
Tax Benefit from Stock Options	-	-	-	-	-
Provision and Write-off of Bad Debts	-	1.21Cr	28.14L	-	-
Other Operating Activities, Total	3.6Cr	-145.33Cr	2.04Cr	3.23Cr	4.72Cr
Change In Accounts Receivable	-12Cr	-14Cr	-26Cr	2.15Cr	-10Cr
Change In Inventories	-5.83Cr	-2.91Cr	-11Cr	-13Cr	3.02Cr
Change In Accounts Payable	2.21Cr	5.22Cr	1.97Cr	-3.65Cr	-77.03L
Change in Unearned Revenues	19Cr	23Cr	46Cr	24Cr	8.67Cr
Change In Income Taxes	1.46Cr	-28.02L	1.24Cr	63.27L	-77.72L
Change in Other Net Operating Assets	2.87Cr	2.1Cr	3.39Cr	-19Cr	-46.86L
Cash from Operations	75Cr	66Cr	117.25Cr	57Cr	79Cr
Capital Expenditure	-15Cr	-15Cr	-40Cr	-29Cr	-18Cr
Cash Acquisitions	-	-42Cr	-80.02L	-1.23Cr	-
Investment in Marketable and Equity Securities, Total	-21Cr	32Cr	-20Cr	9.31Cr	-1.85Cr
Other Investing Activities, Total	71.16L	2.81Cr	4.3Cr	-22.11L	3L
Cash from Investing	-35Cr	-23Cr	-56Cr	-21Cr	-20Cr
Long-Term Debt Repaid, Total	-4.58Cr	-	-	-	-
Total Debt Repaid	-4.58Cr	-	-	-	-
Issuance of Common Stock	1.79Cr	2.03Cr	2.56Cr	2.61Cr	2.66Cr
Repurchase of Common Stock	-46Cr	-5.11Cr	-48Cr	-49Cr	-61Cr
Other Financing Activities, Total	-	-	-	-4Cr	-1Cr
Cash from Financing	-49Cr	-3.08Cr	-46Cr	-50Cr	-60Cr
Foreign Exchange Rate Adjustments	22.82L	1.05Cr	-1.21Cr	-1.15Cr	46.71L
Net Change in Cash	-8.64Cr	41Cr	14Cr	-16Cr	-38.36L
Supplemental Items
Cash Income Tax Paid (Refund)	7.17Cr	7.63Cr	20Cr	23Cr	29Cr
Levered Free Cash Flow	41Cr	50Cr	60Cr	27Cr	62Cr
Unlevered Free Cash Flow	41Cr	50Cr	60Cr	27Cr	62Cr
Change In Net Working Capital	-6.55Cr	-22Cr	-16Cr	10Cr	-8.86Cr
Net Debt Issued / Repaid	-4.58Cr	-	-	-	-

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	14.12	6.6	11.33	6.91	6.82
Return on Total Capital	24.19	10.24	17.27	10.98	10.97
Return On Equity %	34.07	77.55	22.52	10.01	12.31
Return on Common Equity	34.07	77.55	22.52	10.01	12.31
Margin Analysis
Gross Profit Margin %	72.46	71.33	74.26	70.6	70.43
SG&A Margin	44.54	48.58	43.23	44.84	44.1
EBITDA Margin %	24.9	19.45	27.45	20.96	20.69
EBITA Margin %	21.62	16.2	25.12	18.02	17.43
EBIT Margin %	21.38	15.66	24.7	17.59	17
Income From Continuing Operations Margin %	18.4	71.84	19.53	9.68	11.52
Net Income Margin %	18.4	71.84	19.53	9.68	11.52
Net Avail. For Common Margin %	18.4	71.84	19.53	9.68	11.52
Normalized Net Income Margin	13.38	9.99	15.32	10.26	10.59
Levered Free Cash Flow Margin	17.05	20.38	15.07	7.33	15.99
Unlevered Free Cash Flow Margin	17.05	20.38	15.07	7.33	15.99
Asset Turnover
Asset Turnover	1.06	0.67	0.73	0.63	0.64
Fixed Assets Turnover	3.98	3.28	3.91	2.92	2.8
Receivables Turnover (Average Receivables)	4.87	4.09	5.08	4.25	4.38
Inventory Turnover (Average Inventory)	7.91	5.64	5.51	3.86	3.59
Short Term Liquidity
Current Ratio	1.68	1.4	1.3	1.26	1.18
Quick Ratio	1.51	1.26	1.08	1.04	0.98
Operating Cash Flow to Current Liabilities	0.77	0.5	0.61	0.3	0.38
Days Sales Outstanding (Average Receivables)	75.02	89.43	71.79	85.85	83.31
Days Outstanding Inventory (Average Inventory)	46.17	64.89	66.29